Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National HealthcareFRA:HTW -2.11%71 EV-to-EBITDA is 14.36 as of Aug. 15, 2026, which is 55% above its 10-year median of 9.26. GuruFocus rates FRA:HTW with a GF Score™ of 71/100 and a GF Value™ of €111.35. The stock has 5 warning signs investors should review. Among 511 Healthcare Providers & Services companies, National Healthcare ranks worse than 62.43% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, National Healthcare's enterprise value is €2,886 Mil.
National Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €201 Mil. Therefore, National Healthcare's EV-to-EBITDA for today is 14.36.
The historical rank and industry rank for National Healthcare's EV-to-EBITDA or its related term are showing as below:
FRA:HTW'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.16 Med: 9.26 Max: 19.67
Current: 14.25
During the past 13 years, the highest EV-to-EBITDA of National Healthcare was 19.67. The lowest was 4.16. And the median was 9.26.
FRA:HTW's EV-to-EBITDA is ranked worse than 62.43% of 511
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs FRA:HTW: 14.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
National Healthcare (FRA:HTW) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
National Healthcare's PE Ratio (TTM) for today is calculated as:
National Healthcare's share price for today is €186.00.
National Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €7.648.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for National Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HTW vs BKD, OPCH, ACHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, National Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Healthcare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where National Healthcare's EV-to-EBITDA falls into.
National Healthcare's current Enterprise Value is €2,886 Mil.
National Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €201 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Healthcare (FRA:HTW) has a EV-to-EBITDA of 14.36 as of Aug. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on National Healthcare. This is 55% above median its historical median of 9.26. Over the past decade, National Healthcare's EV-to-EBITDA has ranged from 4.16 to 19.67. According to the industry distribution chart, National Healthcare ranks #319 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 62.4%.
Is National Healthcare's EV-to-EBITDA too high?
National Healthcare's current EV-to-EBITDA of 14.36 is 55% above median its 10-year median of 9.26. Over the past 10 years, this metric has ranged from a low of 4.16 to a high of 19.67. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. National Healthcare's value of 14.36 is 33.5% above this industry median. Based on the distribution chart, National Healthcare ranks #319 out of 511 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, National Healthcare has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does National Healthcare's EV-to-EBITDA compare to BKD and OPCH?
According to the Healthcare Providers & Services industry distribution chart, National Healthcare ranks #319 out of 511 companies for EV-to-EBITDA. This places National Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 10.76. National Healthcare's value of 14.36 is 33.5% above this benchmark. Historically, National Healthcare's own EV-to-EBITDA has ranged from 4.16 to 19.67 over the past decade. While the company's 10-year median is 9.26 vs. the industry median of 10.76, National Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Healthcare's current EV-to-EBITDA of 14.36 is 33.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on National Healthcare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Healthcare's current EV-to-EBITDA is 14.36, which is 55% above median its own 10-year median of 9.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Healthcare stock overvalued right now?
National Healthcare (FRA:HTW) has a current EV-to-EBITDA of 14.36. The stock's GF Value™ is €111.35, compared to a current price of €186.00 — trading 67% above its estimated fair value. The current EV-to-EBITDA is 14.36, which is 55% above median its 10-year median of 9.26 and 33.5% above the Healthcare Providers & Services industry median of 10.76. National Healthcare's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For National Healthcare (FRA:HTW), the current EV-to-EBITDA is 14.36 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Healthcare (FRA:HTW) Overvalued in 2026?
Based on GuruFocus' analysis, National Healthcare stock appears to be overvalued.
The current stock price of €186.00 is trading 67% above its estimated GF Value™ of €111.35.
Key valuation signals for FRA:HTW:
EV-to-EBITDA: 14.36 (55% above median its 10-year median of 9.26)
GF Value™: €111.35 vs. price of €186.00 (67% above fair value)
Industry Position: 33.5% above the Healthcare Providers & Services median (#319 of 511)
No single metric tells the full story. See the FRA:HTW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
71GF Score
Get the complete analysis for FRA:HTW
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HTW has been successfully added to your 
